arginine has been researched along with Adrenal Cortex Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Gao, Z; He, J; He, M; Jiang, X; Jiang, Y; Lei, Y; Li, L; Li, X; Li, Y; Liu, L; Ning, G; Peng, Y; Su, T; Wang, H; Wang, J; Wang, W; Wei, Q; Wei, W; Yang, L; Yang, X; Ye, J; Zhong, X; Zhou, W | 1 |
| Demeure, MJ; Doffek, KM; Gorski, J; Komorowski, RA | 1 |
| Melby, JC; Podolsky, S | 1 |
| Eriksson, B; Juhlin, C; Khan, TS; Oberg, K; Sundin, A; Wilander, E | 1 |
1 trial(s) available for arginine and Adrenal Cortex Neoplasms
| Article | Year |
|---|---|
Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer.
Topics: Adrenal Cortex Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 2004 |
3 other study(ies) available for arginine and Adrenal Cortex Neoplasms
| Article | Year |
|---|---|
Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Amino Acid Substitution; Arginine; Catalytic Domain; Cells, Cultured; Cushing Syndrome; Cyclic AMP-Dependent Protein Kinase Catalytic Subunits; Glucocorticoids; Histone-Lysine N-Methyltransferase; Humans; Hydrocortisone; Leucine; Methyltransferases; Microtubule-Associated Proteins; Mutation | 2014 |
Gip-2 codon 179 oncogene mutations: absent in adrenal cortical tumors.
Topics: Adenoma; Adrenal Cortex Neoplasms; Arginine; Base Sequence; Carcinoma; Codon; Cysteine; DNA Restriction Enzymes; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Proteins; Guanosine Triphosphate; Histidine; Humans; Molecular Sequence Data; Oncogenes; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length | 1996 |
Improvement of growth hormone response to stimulation in primary aldosteronism with correction of potassium deficiency.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Arginine; Blood Glucose; Growth Hormone; Humans; Hyperaldosteronism; Insulin; Male; Potassium; Potassium Deficiency | 1976 |